Antidepressants

Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother. 

By |2025-10-09T10:59:51-04:00August 14th, 2025|Antidepressants, Medications and Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off on Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy

Weighing the Evidence: Response to the FDA’s Recent Panel on Antidepressant Use in Pregnancy.

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother. 

By |2025-10-09T10:59:53-04:00July 23rd, 2025|Antidepressants, Psychiatric Disorders During Pregnancy|Comments Off on Weighing the Evidence: Response to the FDA’s Recent Panel on Antidepressant Use in Pregnancy.

Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated

There is evidence that depression itself can increase risk for preeclampsia. In women with more severe depression, treatment with an SSRI antidepressant may decrease risk.

By |2024-06-26T12:55:22-04:00April 11th, 2024|Antidepressants, Pregnancy & Medications, Pregnancy Outcomes, Prevalence & Risk Factors|Comments Off on Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated

Neuroimaging Study Sheds Light on the Impact of Maternal Depression and Prenatal Antidepressant Exposure on Fetal Brain Development

At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.

By |2024-03-23T16:47:06-04:00February 26th, 2024|Antidepressants, Child Outcomes, Depressive Disorders, Neurodevelopmental Disorders, Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on Neuroimaging Study Sheds Light on the Impact of Maternal Depression and Prenatal Antidepressant Exposure on Fetal Brain Development

Treatment of PPD with SSRIs: Long-Term Benefits for Both Mother and Child

Postpartum SSRI treatment mitigated the negative associations between PPD and later maternal depression, partner relationship satisfaction, and child externalizing problems and ADHD symptoms up to 5 years after childbirth.

By |2024-05-16T06:54:38-04:00February 21st, 2024|Antidepressants, Long-Term Outcomes, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Treatment of PPD with SSRIs: Long-Term Benefits for Both Mother and Child

What Has a Greater Effect on Children’s Behavior: Prenatal Exposure to Antidepressants or Maternal Depression?

Maternal depression during the third trimester, not prenatal SSRI exposure, was associated with higher levels of internalizing and anxiety behaviors in children from 3 to 12 years of age.

By |2023-04-17T12:17:02-04:00April 19th, 2023|Antidepressants, Depressive Disorders, Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on What Has a Greater Effect on Children’s Behavior: Prenatal Exposure to Antidepressants or Maternal Depression?
Go to Top